(Reuters) – AstraZeneca said on Thursday its COVID-19 vaccine was effective against the Omicron coronavirus variant following a third dose in a study, with neutralising levels similar to those against the Delta variant after a regular two-dose course.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)
